{"id":141484,"title":"Biologic drugs (Schedule D drugs) – Division 4 proposed regulatory amendments: Notice to stakeholders - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T22:22:24.137000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/biologic-drugs-schedule-d-division-4-proposed-regulatory-amendments-notice.html?wbdisable=false","snippet":"Biologic drugs (Schedule D drugs) – Division 4 proposed regulatory amendments: Notice to stakeholders - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search Menu Main Menu Jobs and the…","rawSnapshotUrl":"/api/snapshots/raw/141484","browseUrl":"https://replay.healtharchive.ca/job-1/20250418222224/https://www.canada.ca/en/health-canada/programs/consultation-proposed-agile-regulations-guidance-licensing-drugs-medical-devices/biologic-drugs-schedule-d-division-4-proposed-regulatory-amendments-notice.html?wbdisable=false#ha_snapshot=141484","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}